![Drew Deniger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Drew Deniger formerly worked at Alaunos Therapeutics, Inc., as Vice President-Research & Development from 2022 to 2023.
Dr. Deniger received his doctorate degree in 2013 from Anderson University and undergraduate degree in 2002 from The University of Texas at Austin.
Anciens postes connus de Drew Deniger
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 15/11/2023 |
Formation de Drew Deniger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Anderson University
 Anderson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
